Le Lézard
Classified in: Science and technology
Subject: PDT

Borderless Access Launches 'TAPP' - Key to the World of Consumer Behaviour and Emotions


BANGALORE, India, February 20, 2018 /PRNewswire/ --

Borderless Access, a global Digital MR Solutions Company, brings diverse consumer behaviour, emotions, and micro-moments within easy reach of brands with its new revolutionary product 'TAPP' This launch is in line with its vision to be the global leader in providing digital market research solutions for understanding consumer experiences and behaviours, in growth and developed markets of the world; driven by advanced Analytics and Technology.

     (Logo: http://photos.prnewswire.com/prnh/20161017/429158LOGO )

Commenting on the launch of TAPP, Ruchika Gupta, CEO of Borderless Access, said, "As smartphones, social media and other digital communication platforms usage grows, it offers extensive opportunities to understand consumer behaviour in real-time and greater detail than ever before. This can be a boon for brands that are always looking for ways to reach out to their customers at the right moment to offer their products and services. With our years of experience in understanding consumers across geographies, we built TAPP, which has been pilot tested with two major global brands, allowing them to understand life moments and experiences of consumers at different timeslots and locations."

The product TAPP identifies patterns and trends by looking into consumers' interactions and their emotional state and behaviour within their environment with its unique methodologies and machine learning algorithms for rich, easy to interpret, actionable insights for brands. With TAPP, marketers and researchers can understand consumers' micro-moments to develop communication, manage brand activation, test concepts, evolve products, and much more.

TAPP empowers marketers and researchers to target in-situ and efficiently develop content as per their stories.

About Borderless Access:  

Borderless Access, a global digital MR solutions company, provides access to experiences and life moments of engaged consumers from hard-to-reach audiences (Consumers, B2B & Specialist Audiences, including Healthcare) in the emerging and developed markets, driven by Technology & Community Analytics to its global clientele of MR firms, Ad Agencies, Consultancy firms, and End Enterprises.

Its focus on innovation extends to providing market research products & solutions, such as Panel Solutions, SmartSight, HealthSight, and TAPP.

Media Contact: 
Anshul Agarwal
[email protected]  


SOURCE Borderless Access Panels Pvt Ltd.


These press releases may also interest you

at 07:10
D-Wave Quantum Inc., ("D-Wave" or the "Company") a leader in commercial quantum computing systems, software, and services, today announced financial results for its fourth fiscal quarter and year ended December 31, 2023. "Our momentum is...

at 07:10
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced financial results and clinical updates for the twelve months ended...

at 07:10
Zilliant, the leader in pricing lifecycle management, today announced it recently concluded a year of rapid growth, delivering two consecutive quarters of 60%+ growth in year-over-year bookings. The company is positioned for continued record growth...

at 07:10
Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced the appointments of global leaders in cell therapy and drug development, Kristen Hege, M.D., and Mathai Mammen, M.D., Ph.D., to its board of directors....

at 07:07
MESCIUS inc., a global provider of award-winning enterprise software development tools, is pleased to announce the release of ActiveReports. NET v18. This major release includes exciting new features and improvements to the ActiveReports ecosystem....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the clinical development plan intended to enable...



News published on and distributed by: